<DOC>
	<DOC>NCT00370318</DOC>
	<brief_summary>The purpose of this trial is to assess if the rate of febrile reactions following the co-administration of pneumococcal conjugate vaccines with standard infant vaccines is lowered when paracetamol is given prophylactically.</brief_summary>
	<brief_title>Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines</brief_title>
	<detailed_description>2 groups (200 per group); control group receives no prophylactic antipyretic treatment.</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Healthy children 916 weeks old and born after a gestation of at least 36 weeks. Body weight &lt; 4.5 kg Children having received or planning to receive any investigational or nonregistered products, vaccines not foreseen in the protocol, and immune modifying drugs Children with any disease that affects the immune system or gastrointestinal tract Children with a history of seizures, allergic disease, or disease(s) covered by the vaccines Children with contraindication to paracetamol treatment.</criteria>
	<gender>All</gender>
	<minimum_age>9 Weeks</minimum_age>
	<maximum_age>16 Weeks</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Pneumococcal Disease</keyword>
</DOC>